@article{e3bc49e0c5d24a9698eee3e81b5118fd,
title = "Drug policy for visceral leishmaniasis: a cost-effectiveness analysis",
keywords = "B780-tropical-medicine, Protozoal diseases, Leishmaniasis, Visceral, Kala azar, Drug therapy, Antiprotozoal agents, Cost-effectiveness, Amphotericin B, Miltefosine, Ambisome, Antimonials, Sodium stibogluconate, Generics, Adverse effects, Drug resistance",
author = "V Vanlerberghe and G Diap and PJ Guerin and F Meheus and S Gerstl and {Van der Stuyft}, P and M Boelaert",
note = "ITG-H1A; ITG-H6A; ITG-HLA; HEALTH; U-EPID; JIF; DOI; PDF",
year = "2007",
doi = "10.1111/j.1365-3156.2006.01782.x",
language = "English",
volume = "12",
pages = "274--283",
journal = "Tropical Medicine and International Health",
issn = "1360-2276",
publisher = "John Wiley & Sons",
number = "2",
}